Company · Ownership research

Axogen, Inc. AXGN

CIK 0000805928

Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 38 rows; the complete set is available through the API.

Insider filings on file run through Sep 4, 2026.

Insider purchases & sales

Purchased: $0.00
Sold: $22.14M

Nov 1, 2023 – Sep 4, 2026
Available records · partial months are marked ·

202510 of 30 preview events · 38 available in 2025

Date	Insider	Activity	Trade value (USD)	% of prior holding
Dec 16, 2025	Wendell Amy McBride Director	Sale	$1.28M 43,684 shares sold	31.77% sold Direct holding	▾
Dec 16, 2025	Weiler Kathy Johnson Director	Sale	$1.38M 46,653 shares sold	100.00% sold Direct holding	▾
Dec 15, 2025	Hartley Lindsey Marie CFO	Sale	$442.29K 14,812 shares sold	32.07% sold Direct holding	▾
Dec 11, 2025	Began Marc A EVP & General Counsel	Sale	$396.66K 13,222 shares sold	41.97% sold Direct holding	▾
Dec 10, 2025	DALE MICHAEL D Chief Executive Officer	Sale	$750.00K 25,000 shares sold	28.24% sold Direct holding	▾
Dec 9, 2025	JOHNSON JOHN Director	Sale	$650.19K 21,686 shares sold	100.00% sold Direct holding	▾
Dec 9, 2025	DALE MICHAEL D Chief Executive Officer	Sale	$1.92M 61,463 shares sold	40.98% sold Direct holding	▾
Dec 9, 2025	TYNDALL JOSEPH A. Director	Sale	$777.77K 25,108 shares sold	100.00% sold Direct holding	▾
Dec 9, 2025	DeVinney Erick Wayne Chief Innovation Officer	Sale	$609.09K 19,517 shares sold	7.49% sold Direct holding	▾
Dec 9, 2025	Kemp Jens Chief Marketing Officer	Sale	$254.53K 8,156 shares sold	15.05% sold Direct holding	▾

Showing 30 / 38 record groups in 2025. The complete set is available through the API.

Axogen, Inc. · AXGN

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 38 purchase / sale groups and 30 of 71 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"AXGN","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.